
1. j biol chem. 2003 mar 7;278(10):7884-90. epub 2003 jan 2.

fibrates down-regulate hepatic scavenger receptor class b type protein
expression mice.

mardones p(1), pilon a, bouly m, duran d, nishimoto t, arai h, kozarsky kf,
altayo m, miquel jf, luc g, clavey v, staels b, rigotti a.

author information: 
(1)departamento de gastroenterologia, facultad de medicina, pontificia
universidad cat√≥lica, marcoleta 367, santiago, chile.

fibrates normolipidemic drugs used atherogenic dyslipidemia of
their ability raise high density lipoprotein (hdl) decrease triglyceride
levels. exert multiple effects lipid metabolism activating the
peroxisome proliferator-activated receptor-alpha (ppar-alpha), controls the
transcriptional regulation genes involved hepatic fatty acid, cholesterol, 
and lipoprotein metabolism. hepatic expression scavenger receptor
class b type (sr-bi) plays critical role lipoprotein metabolism, mainly
due ability mediate selective cholesterol uptake. fibrates 
ppar-alpha agonists up-regulate sr-bi expression human murine macrophages,
we tested whether fibrates raised similar regulatory response hepatic sr-bi 
expression mice. surprisingly, fibrate treatment suppressed sr-bi protein
expression liver without changing steady state sr-bi mrna levels.
decreased hepatic sr-bi protein expression correlated enlarged hdl particle 
size. effect concomitant down-regulation clamp, putative
sr-bi-stabilizing protein found hepatic plasma membrane, also
not associated changes clamp mrna levels. post-transcriptional
regulatory effect fibrates hepatic sr-bi protein levels dependent 
ppar-alpha expression, absent ppar-alpha-deficient mice.
restoring hepatic sr-bi expression fibrate-treated mice recombinant
adenoviral gene transfer abolished fibrate-mediated hdl particle size
enlargement. study describes novel effect fibrates hepatic sr-bi
expression providing alternative mechanism drug family modulates
hdl metabolism vivo.

doi: 10.1074/jbc.m211627200 
pmid: 12511553  [indexed medline]

